Status:
COMPLETED
Single In-Clinic Encounter With the Notal Vision Home OCT by DME Patients
Lead Sponsor:
Notal Vision Inc.
Conditions:
Diabetic Retinopathy
Eligibility:
All Genders
18+ years
Brief Summary
In this clinical study the Notal Vision Home OCT (NVHO) Monitoring System will be used to evaluate the ability of patients diagnosed with DME to perform sequential self-images of their eyes with the s...
Detailed Description
Office Visit NOTE: Any planned treatment for DME at the day of the study should be administered after completion of all study-related scans At the enrollment Office Visit, the exams will be conducted...
Eligibility Criteria
Inclusion
- Ability to speak, read and understand Hebrew.
- Ability to understand and agree to contents of informed consent.
- Eighteen (18) years of age or older at the time of Informed Consent.
- Subjects diagnosed with DR (Diabetic Retinopathy) in at least one eye, with or without DME
- Best corrected Visual Acuity of 20/320 (6/96) or better in eyes participating at the study.
Exclusion
- Subjects with dilated pupils.
- Subjects with other retinal disease requiring steroidal or anti-VEGF injections.
Key Trial Info
Start Date :
June 29 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2023
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT05417152
Start Date
June 29 2022
End Date
March 30 2023
Last Update
June 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assuta Hashalom
Tel Aviv, Israel